1. Gu, Xinpei, Chen, Shuhui, Wang, Zhaojin, Bu, Qianwen, An, Shuhong. 2023. LZTS3/TAGLN Suppresses Cancer Progression in Human Colorectal Adenocarcinoma Through Regulating Cell Proliferation, Migration, and Actin Cytoskeleton. In Archives of medical research, 54, 102894. doi:10.1016/j.arcmed.2023.102894. https://pubmed.ncbi.nlm.nih.gov/37806182/
2. Ye, Kui, Cao, Huaxiang, Xu, Zihao, Wang, Teng, Wang, Jian. 2025. Identification of the oncogenic role and clinical implication of LZTS3 in Colon Adenocarcinoma. In Journal of Cancer, 16, 81-91. doi:10.7150/jca.102204. https://pubmed.ncbi.nlm.nih.gov/39744581/
3. Langmyhr, Margrete, Henriksen, Sandra Pilar, Cappelletti, Chiara, Pihlstrøm, Lasse, Toft, Mathias. 2021. Allele-specific expression of Parkinson's disease susceptibility genes in human brain. In Scientific reports, 11, 504. doi:10.1038/s41598-020-79990-9. https://pubmed.ncbi.nlm.nih.gov/33436766/
4. Teufel, Andreas, Weinmann, Arndt, Galle, Peter R, Lohse, Ansgar W. . In silico characterization of LZTS3, a potential tumor suppressor. In Oncology reports, 14, 547-51. doi:. https://pubmed.ncbi.nlm.nih.gov/16012743/
5. Chevalier, Guenson, Udovin, Lucas, Otero-Losada, Matilde, Goetz, Christopher G, Perez-Lloret, Santiago. 2023. Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease, Results from a Cross-Sectional In Silico Study. In Brain sciences, 13, . doi:10.3390/brainsci13030506. https://pubmed.ncbi.nlm.nih.gov/36979316/